Ketamine’s Psychedelic Effects May Not Be Why It Treats Alcohol Addiction
A new study from King’s College London and the University of Exeter is challenging a popular assumption in ketamine therapy. The finding is simple but significant: the intense psychedelic experiences patients report during treatment do not appear to drive ketamine’s success in reducing alcohol use. Published in the journal Addiction, the research analyzed data from 96 participants in the KARE clinical trial and tracked outcomes over six months.
Do you work in the ketamine industry? We launched the Healing Health Alliance, which is the first national provider network and GPO (Group Purchasing Organization) exclusively for ketamine practitioners and clinic owners. We will bring you significant cost savings and revenue generating opportunities. There’s no cost or obligation and you can join now!
| Key Takeaway | Details |
|---|---|
| Study Size | 96 adults with moderate to severe alcohol use disorder |
| Design | Randomized, placebo controlled, six month follow up |
| Treatment Protocol | Three weekly IV ketamine infusions paired with psychotherapy |
| Core Finding | Psychedelic intensity did not predict abstinence rates |
| Tolerance Effect | No tolerance developed across three sessions |
| Proposed Mechanism | Brain network changes and new neural connections |
| Next Steps | Larger MORE KARE trial now recruiting across the UK |
New:Â Interested in Being Part of a Psychedelics-Focused Clinical Trial? Sign Up Here
Most clinics spend 4-6 weeks navigating Spravato REMS certification — chasing paperwork, decoding FDA requirements, and wondering if they missed a step. Our AI-powered REMS Certification Assistant cuts that to one sitting. Get a personalized checklist of exactly what you need, and walk into the REMS portal ready to submit.
Get the REMS Certification Assistant →The Assumption Under Scrutiny
For years, researchers theorized that ketamine works because of its psychedelic effects. The logic seemed intuitive. Patients reported vivid altered states, feelings of disembodiment and perceptual shifts. Earlier, smaller studies even suggested these mystical experiences correlated with reduced drinking. A 2020 secondary analysis of 40 participants found that mystical effects measured by the Hood Mysticism Scale mediated the relationship between ketamine and reduced heavy drinking.
The new KARE analysis tells a different story. Participants who received ketamine did experience dramatic psychoactive effects compared to placebo. They described altered reality, out of body sensations and perceptual distortions. These effects stayed consistent across all three infusion sessions. Yet the intensity of those experiences did not predict how many days a patient stayed sober.
What Is Actually Working
If the “trip” is not the medicine, what is? The researchers point to ketamine’s known neurobiological effects. The drug blocks NMDA receptors and promotes neuroplasticity. It can rewire brain networks involved in addiction. It may stimulate the growth of entirely new neural connections. These mechanisms operate independently of what a patient feels during an infusion.
This distinction matters for treatment design. Consider what it means for clinics focused on creating optimal psychedelic environments. If the subjective experience is not the active ingredient, providers may need to rethink how they frame treatment for patients.
Why This Matters Now
Professor Celia Morgan, the KARE study lead, noted that over 85,000 people in England receive treatment for alcohol use disorder annually. Many more go untreated. The need for diverse, effective options remains urgent.
The research team is now expanding their work through the MORE KARE trial, an NHS funded study recruiting participants across the United Kingdom. This larger trial aims to investigate the role of brain connectivity changes in ketamine’s therapeutic effects and to refine dosing protocols.
For the ketamine therapy community, this study offers an important recalibration. The clinical value of ketamine for alcohol use disorder appears real. The reason it works may just be more biological than mystical.
